Logo Image

Shorts

Overviewing Phase 3 DAWN Efficacy Data of Daratumumab in NMOSD
0:35
Overviewing Phase 3 DAWN Efficacy Data of Daratumumab in NMOSD
7 months ago
by
Michael Levy, MD, PhD(+1 more)
Why Some RLS Medications Can Make Symptoms Worse
0:58
Why Some RLS Medications Can Make Symptoms Worse
7 months ago
by
Louie Pasculli
Meeting the Needs of Underserved Multiple Sclerosis Populations
1:33
Meeting the Needs of Underserved Multiple Sclerosis Populations
7 months ago
by
Marisa McGinley, DO(+1 more)
Early Identification and Newborn Screening for Neuromuscular Disorders
0:37
Early Identification and Newborn Screening for Neuromuscular Disorders
7 months ago
by
John F. Brandsema, MD(+1 more)
Data Behind EBNA1 Antibodies as Distinguishable Feature of Multiple Sclerosis
2:00
Data Behind EBNA1 Antibodies as Distinguishable Feature of Multiple Sclerosis
7 months ago
by
Marco Meglio
4 FDA-Approved Treatments for NMOSD You Should Know
1:10
4 FDA-Approved Treatments for NMOSD You Should Know
7 months ago
by
Louie Pasculli
Clinical Value of EBNA1 Antibodies in MS, MOGAD, & NMOSD
1:24
Clinical Value of EBNA1 Antibodies in MS, MOGAD, & NMOSD
7 months ago
by
Marco Meglio
Emerging CAR-T Therapy Approaches in NMOSD
1:01
Emerging CAR-T Therapy Approaches in NMOSD
7 months ago
by
Louie Pasculli
Addressing Access Barriers to Emerging Therapies in Neuromuscular Disease
0:31
Addressing Access Barriers to Emerging Therapies in Neuromuscular Disease
7 months ago
by
Isabella Ciccone, MPH(+1 more)
Developing Pivotal Trials for Stem Cell-Based Agents in Multiple Sclerosis
1:33
Developing Pivotal Trials for Stem Cell-Based Agents in Multiple Sclerosis
7 months ago
by
Jeffrey Cohen, MD(+1 more)
MDA 2026: Accepting the MDA Legacy Award
0:48
MDA 2026: Accepting the MDA Legacy Award
7 months ago
by
Allison Moore(+1 more)
How Deramiocel Works
1:02
How Deramiocel Works
7 months ago
by
Noah Stansfield
Research and Collaboration in Neuromuscular Medicine
0:51
Research and Collaboration in Neuromuscular Medicine
7 months ago
by
Marco Meglio(+1 more)
MDA 2026: Receiving the MDA Legacy Award
0:51
MDA 2026: Receiving the MDA Legacy Award
7 months ago
by
Michio Hirano, MD(+1 more)
MDA 2026: Future Vision of Neuromuscular Disorders
0:51
MDA 2026: Future Vision of Neuromuscular Disorders
7 months ago
by
Isabella Ciccone, MPH(+1 more)
MDA 2026: Phase 2 ALKIVIA Study
0:31
MDA 2026: Phase 2 ALKIVIA Study
7 months ago
by
Isabella Ciccone, MPH(+1 more)
MDA 2026: In the Shoes of the Patient
0:47
MDA 2026: In the Shoes of the Patient
7 months ago
by
Isabella Ciccone, MPH(+1 more)
MDA 2026: The Future of Precision Medicine
0:51
MDA 2026: The Future of Precision Medicine
7 months ago
by
Isabella Ciccone, MPH(+1 more)
Reasons Behind Eptinezumab's Effectiveness in Treatment-Resistant Migraine
1:33
Reasons Behind Eptinezumab's Effectiveness in Treatment-Resistant Migraine
7 months ago
by
Marco Meglio(+1 more)
Managing Neurologic Symptoms During Cancer Treatment
0:56
Managing Neurologic Symptoms During Cancer Treatment
7 months ago
by
Ditte Primdahl, MD(+2 more)
Navigating Neurologic Complications During Cancer Therapy
0:49
Navigating Neurologic Complications During Cancer Therapy
7 months ago
by
Shailee Samir Shah, MD(+2 more)
Primary Care–Neurologist Collaboration After Stroke
1:32
Primary Care–Neurologist Collaboration After Stroke
7 months ago
by
Eva Mistry, MD (+1 more)
Assessing Potential of BD-Tau in Stroke-Related Brain Injury
1:33
Assessing Potential of BD-Tau in Stroke-Related Brain Injury
7 months ago
by
Marco Meglio(+1 more)
Optimizing Immunotherapy in PNS During Cancer Care
0:55
Optimizing Immunotherapy in PNS During Cancer Care
7 months ago
by
Ditte Primdahl, MD(+2 more)
Managing Immunotherapy and Recovery in PNS
0:59
Managing Immunotherapy and Recovery in PNS
7 months ago
by
Shailee Samir Shah, MD(+2 more)
Differentiating PNS From Treatment-Related Neurotoxicity
1:00
Differentiating PNS From Treatment-Related Neurotoxicity
7 months ago
by
Shailee Samir Shah, MD(+2 more)
Challenges in Diagnosing Paraneoplastic Neurologic Syndromes
1:01
Challenges in Diagnosing Paraneoplastic Neurologic Syndromes
7 months ago
by
Ditte Primdahl, MD(+2 more)
Differentiating Classic PNS from ICI-Related Toxicities
1:11
Differentiating Classic PNS from ICI-Related Toxicities
8 months ago
by
Ditte Primdahl, MD(+2 more)
Managing PNS in the Era of Immunotherapy
0:27
Managing PNS in the Era of Immunotherapy
8 months ago
by
Shailee Samir Shah, MD(+2 more)
Prioritizing Malignancy Screening in Suspected PNS
1:07
Prioritizing Malignancy Screening in Suspected PNS
8 months ago
by
Ditte Primdahl, MD(+2 more)